GEMMABio raises $34m to advance gene therapy programmes 

This seed funding comes after GEMMABio secured $100m in October through a partnership with Brazilian supplier Fiocruz.

Related Posts

CMN-005 by CoImmune for Extranodal Marginal Zone B-Cell...

Sep 10, 2024

Risk adjusted net present value: What is the current va...

Apr 17, 2024

Grifols prepares for late-stage plans with plasma-deriv...

Feb 28, 2024